Cargando...

Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes

Despite the promise of RNA interference (RNAi) and its potential, e.g. for use in cancer therapy, several technical obstacles must first be overcome. The major hurdle of RNAi-based therapeutics is to deliver nucleic acids across the cell’s plasma membrane. This study demonstrates that exosome vesicl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wahlgren, Jessica, Karlson, Tanya De L., Brisslert, Mikael, Vaziri Sani, Forugh, Telemo, Esbjörn, Sunnerhagen, Per, Valadi, Hadi
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3458529/
https://ncbi.nlm.nih.gov/pubmed/22618874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gks463
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!